A Randomized, Double-mask, Four-period Crossover Study in Healthy Subjects to Evaluate the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2014
At a glance
- Drugs Alcohol; Tasimelteon
- Indications Major depressive disorder; Sleep disorders
- Focus Pharmacodynamics
- Sponsors Vanda Pharmaceuticals
- 19 Jun 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2012 New trial record